Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Several clinicopathological features of clear cell renal cell carcinomas (ccRCC) contribute to make an “atypical” cancer, including resistance to chemotherapy, sensitivity to anti-angiogenesis therapy and ICIs despite a low mutational burden, and CD8<sup>+</sup> T cell infiltration being...
Guardado en:
Autores principales: | Myung-Chul Kim, Zeng Jin, Ryan Kolb, Nicholas Borcherding, Jonathan Alexander Chatzkel, Sara Moscovita Falzarano, Weizhou Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbaf6739b9e74a16a70b4da304890e3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Bin Zheng, et al.
Publicado: (2021) -
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Lu Zhang, et al.
Publicado: (2021) -
Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Aimin Jiang, et al.
Publicado: (2021) -
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
por: Yann-Alexandre Vano, et al.
Publicado: (2021) -
Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma
por: Marcela Cechova, et al.
Publicado: (2021)